Clinical Trial Update: Psychostimulants for Fatigue in Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating psychostimulants to treat fatigue in patients with prostate cancer; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Fatigue, Prostate Cancer | Phase 2 | Status: COMPLETED